NutriBand Inc.
NTRBNasdaqCIK 1676047HealthcareFiscal year ends Jan 31
Reports and events: 152 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2317:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-102721 |
| 2026-09-1515:48 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-100103 |
| 2026-09-0416:31 ET | 10-Q | Quarterly reportPeriod 2026-07-31 | 0001213900-26-097701 |
| 2026-06-2208:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-070378 |
| 2026-06-1116:20 ET | 10-Q | Quarterly reportPeriod 2026-04-30 | 0001213900-26-067840 |
| 2026-05-1816:44 ET | 10-K/A | Annual report, amendedPeriod 2026-01-31 | 0001213900-26-058507 |
| 2026-04-2917:13 ET | 10-K | Annual reportPeriod 2026-01-31 | 0001213900-26-049399 |
| 2026-04-0715:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-041006 |
| 2026-02-1316:58 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-016550 |
| 2026-02-0313:44 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-011304 |
| 2025-12-3016:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-126650 |
| 2025-12-1911:01 ET | DEF 14A | Proxy statementPeriod 2026-01-24 | 0001213900-25-123599 |
| 2025-12-1117:41 ET | 10-Q | Quarterly reportPeriod 2025-10-31 | 0001213900-25-120204 |
| 2025-10-2812:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-102930 |
| 2025-09-0917:27 ET | 10-Q | Quarterly reportPeriod 2025-07-31 | 0001213900-25-086270 |
| 2025-09-0313:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-083882 |
| 2025-08-0716:47 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-25-073116 |
| 2025-07-1617:54 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-25-064355 |
| 2025-05-3016:02 ET | 10-Q | Quarterly reportPeriod 2025-04-30 | 0001213900-25-049455 |
| 2025-05-1317:29 ET | 10-K/A | Annual report, amendedPeriod 2025-01-31 | 0001213900-25-042792 |
| 2025-04-2817:21 ET | 10-K | Annual reportPeriod 2025-01-31 | 0001213900-25-036201 |
| 2025-04-0911:41 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-030175 |
| 2025-03-1318:10 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-25-023797 |
| 2025-03-1318:07 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-25-023793 |
| 2025-02-1311:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-013266 |
| 2025-02-1216:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-012896 |
| 2025-01-2917:22 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-007938 |
| 2024-12-3015:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-113463 |
| 2024-12-1611:35 ET | DEF 14A | Proxy statementPeriod 2025-01-23 | 0001213900-24-109109 |
| 2024-12-0420:47 ET | 10-Q | Quarterly reportPeriod 2024-10-31 | 0001213900-24-105201 |
| 2024-10-3112:38 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-092676 |
| 2024-09-1911:38 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-080124 |
| 2024-09-1813:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-079788 |
| 2024-09-0317:12 ET | 10-Q | Quarterly reportPeriod 2024-07-31 | 0001213900-24-075159 |
| 2024-06-0315:25 ET | 8-K/A | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-24-049007 |
| 2024-05-3113:54 ET | 10-Q | Quarterly reportPeriod 2024-04-30 | 0001213900-24-048363 |
| 2024-05-2118:16 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-24-045330 |
| 2024-05-1717:44 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-24-044425 |
| 2024-05-0118:51 ET | 10-K | Annual reportPeriod 2024-01-31 | 0001213900-24-037996 |
| 2024-04-2314:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-035276 |
| 2024-03-2817:14 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-027338 |
| 2024-01-2516:40 ET | 8-K | 5.07 Shareholder vote results | 0001213900-24-006496 |
| 2024-01-2310:53 ET | SC 13D | Ownership report, active investor | 0001213900-24-005531 |
| 2024-01-1117:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-003023 |
| 2023-12-2917:25 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-23-100093 |
| 2023-12-1517:49 ET | DEF 14A | Proxy statementPeriod 2024-01-21 | 0001213900-23-095793 |
| 2023-12-1321:05 ET | 10-Q | Quarterly reportPeriod 2023-10-31 | 0001213900-23-095208 |
| 2023-09-1118:00 ET | 10-Q | Quarterly reportPeriod 2023-07-31 | 0001213900-23-075508 |
| 2023-07-1409:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-23-056939 |
| 2023-07-0621:56 ET | S-1/A | Registration statement, amended | 0001213900-23-054976 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.